Page 4 - The Portugal News - Online Edition
P. 4

News
      4 The Portugal News • 18 Jan 2020


      Five companies to grow medicinal cannabis




      Five companies have obtained authorisation from Portugal’s National Medicines Authority (Infarmed) to grow, import and
      export cannabis for medicinal purposes, over a total cultivation area of 120 hectares, according to data released to Lusa.

                                                                                              Regarding applications for   substances based on the
                                                                                              authorisation to place cannabis  cannabis plant for medicinal
                                                                                              plant preparations on the    purposes, namely the
                                                                                              market for medicinal purposes,  prescription and dispensing in a
                                                                                              Infarmed said that two       pharmacy.
                                                                                              applications have been       The entire production chain,
                                                                                              received, which are under    from the cultivation of the plant
                                                                                              evaluation.                  to its preparation and
                                                                                              In April last year, the drug  distribution, is known and
                                                                                              authority created the Office of  controlled, and it is possible to
                                                                                              Cannabis for Medicinal       ensure that products are
                                                                                              Purposes, with members from  produced in accordance with all
                                                                                              various areas (licensing,    applicable good practices and
                                                                                              inspection, evaluation,      requirements.
                                                                                              communication and legal      In this way, it is guaranteed that
                                                                                              advice), which has been      patients have access to
                                                                                              working constructively with  products with quality and safety,
                                                                                              companies, patient           not being exposed to
                                                                                              associations, specialised press  unnecessary and avoidable
                                                                                              and various public entities.  risks, preventing their misuse
                                                                                              Communication on this matter  and limiting their use to cases
                                                                                              has been a concern, which has  where conventional treatments
                                                                                              also led to the creation of an  have not produced the expected
                                                                                              area on its website that gathers  effects or have caused relevant
                                                                                              all relevant information     adverse effects, Infarmed said.
                                                                                              (www.infarmed.pt/web/        The use of these products
                                                                                              infarmed/canabis-medicinal).  depends on the medical
                                                                                              This theme has been the object  assessment and their dispensing
                                                                                              of much interest, especially of  can only be carried out in the
       The entire production chain, from the cultivation of the plant to its preparation and distribution, is known
       The entire production chain, from the cultivation of the plant to its preparation and distribution, is known
       The entire production chain, from the cultivation of the plant to its preparation and distribution, is known  the companies and entities that  pharmacy on prescription.
       The entire production chain, from the cultivation of the plant to its preparation and distribution, is known
       The entire production chain, from the cultivation of the plant to its preparation and distribution, is known
       and controlled by Infarmed. (Photo: EPA/Darren England)
       and controlled by Infarmed. (Photo: EPA/Darren England)
       and controlled by Infarmed. (Photo: EPA/Darren England)
       and controlled by Infarmed. (Photo: EPA/Darren England)                                intend to dedicate themselves  Among the indications for the
       and controlled by Infarmed. (Photo: EPA/Darren England)
                                                                                              to this activity. Thus, in the year  use of these products are
            everal requests for     was published in the country’s  Cantanhede and Reguengos  2019, 1,304 requests for     chronic pain associated with
            authorisation to carry out  state journal on 15 January  de Monsaraz.             information on cannabis were  oncologic diseases, epilepsy
            various activities, such  2019 and came into effect on  The other companies with  answered (14 percent of the  and treatment of severe seizure
      Sas growing,                  1 February.                  authorisation for growing,   answers given by the Infarmed  disorders in childhood, multiple
      manufacturing, import, export  One of the companies, “Tilray  import and export are ‘Terra  Information Centre), Infarmed  sclerosis, nausea and vomiting
      and wholesale distribution,   Portugal”, has a certificate of  Verde’ in Alcochete, ‘RPK  said.                      caused by chemotherapy,
      have been received Infarmed   Good Manufacturing Practice,  Biopharma’ in Sintra and    In July 2018, the parliament  appetite stimulation in the
      said in a report on the first year  in addition to the authorisation  Aljustrel, ‘Sabores Purpura’ in  passed the law establishing the  palliative care of patients
      of legalisation of cannabis use  for cultivation, import and  Tavira and ‘VF 1883       legal framework for the use of  undergoing oncologic
      for medicinal purposes, which  export in the area of       Pharmaceuticals’ in Benavente.  medicines, preparations and  treatment or with AIDS.
   1   2   3   4   5   6   7   8   9